Terns Pharmaceuticals shares are trading higher after JMP Securities raised its price target on the stock from $15 to $20.
Portfolio Pulse from Benzinga Newsdesk
Terns Pharmaceuticals shares are experiencing an increase in trading activity following JMP Securities' decision to raise its price target from $15 to $20.
September 10, 2024 | 2:12 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JMP Securities has increased its price target for Terns Pharmaceuticals from $15 to $20, leading to a rise in the company's stock price.
The increase in the price target by JMP Securities is a positive signal to investors, suggesting confidence in Terns Pharmaceuticals' future performance. This has led to an increase in the stock price as investors react to the upgraded target.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100